OTCMKTS:TPIY Tianyin Pharmaceutical (TPIY) Stock Price, News & Analysis $0.0001 +0.00 (+∞) As of 07/15/2019 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Tianyin Pharmaceutical Stock (OTCMKTS:TPIY) Get Tianyin Pharmaceutical alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0178Volume88,900 shsAverage Volume36,100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Tianyin Pharmaceutical Company, Inc. (OTCMKTS: TPIY) is a U.S.-registered holding company whose principal operations are conducted through its subsidiaries in China. The company specializes in the research, development, production and marketing of modern Chinese pharmaceutical and nutraceutical products. Tianyin Pharmaceutical’s manufacturing facilities adhere to Good Manufacturing Practices (GMP) standards, supporting a range of dosage forms including tablets, capsules, granules and injectable preparations. The company’s product portfolio comprises both prescription and over-the-counter (OTC) offerings rooted in traditional Chinese medicine principles. Its branded therapeutic products address cardiovascular, respiratory and metabolic health, while its nutraceutical line includes herbal supplements formulated to support general wellness. Tianyin Pharmaceutical distributes its products through an established network of hospitals, clinics, retail pharmacies and regional distributors across mainland China. Committed to innovation, Tianyin Pharmaceutical maintains research and development efforts focused on standardizing herbal formulations, conducting clinical trials and securing regulatory approvals from China’s National Medical Products Administration. The company leverages partnerships with academic institutions and research organizations to advance proprietary drug candidates. With its corporate headquarters in Nevada and operational headquarters in Zhejiang Province, Tianyin Pharmaceutical serves the growing domestic market for integrative medicine solutions in the People’s Republic of China.AI Generated. May Contain Errors. Read More Receive TPIY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tianyin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TPIY Stock News HeadlinesTasly Pharmaceutical Group Co. Ltd. AMarch 17, 2023 | wsj.comTianjin Chase Sun Pharmaceutical Co Ltd (300026)March 2, 2023 | uk.investing.com$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…May 19 at 1:00 AM | Paradigm Press (Ad)Tianjin Chase Sun Pharmaceutical Co. Ltd.February 28, 2023 | wsj.comArrowhead Pharmaceuticals Requires CautionFebruary 25, 2023 | seekingalpha.comA Look At The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)February 23, 2023 | uk.finance.yahoo.comTianjin Tianyao Pharmaceutical Co. Ltd.February 23, 2023 | wsj.comTianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class SFebruary 22, 2023 | morningstar.comMSee More Headlines TPIY Stock Analysis - Frequently Asked Questions How have TPIY shares performed this year? Tianyin Pharmaceutical's stock was trading at $0.0001 at the start of the year. Since then, TPIY stock has increased by 0.0% and is now trading at $0.0001. How do I buy shares of Tianyin Pharmaceutical? Shares of TPIY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tianyin Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tianyin Pharmaceutical investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:TPIY Previous SymbolNYSEMKT:TPI CIK1362718 Webwww.tianyinpharma.com Phone00-86-028-8551-6696FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta54.39 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:TPIY) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tianyin Pharmaceutical Inc Co Please log in to your account or sign up in order to add this asset to your watchlist. Share Tianyin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.